Hospital
East Carolina Health-Bertie
East Carolina Health-Bertie was paid $5.47M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.
33Billing provider infoEAST CAROLINA HEALTH-BERTIE
WINDSOR, NC 27983
WINDSOR, NC 27983
33aNPI1013999705assigned 11/17/2005
33bProvider typeCritical Access Hospital
28Total paid$5.47M
24GClaims63,648
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in North Carolina
Rank by total paid#4 of 25
Median peer was paid$1.32M
This provider vs. median4.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,232 | $746K | |
| 2019 | 7,565 | $715K | |
| 2020 | 3,696 | $296K | |
| 2021 | 7,712 | $647K | |
| 2022 | 9,789 | $937K | |
| 2023 | 11,728 | $1.08M | |
| 2024incomplete | 12,926 | $1.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 42% | 12,734 | 12,168 | $2.28M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 5,400 | 5,136 | $1.29M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.8% | 1,669 | 1,564 | $369K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 6.1% | 2,371 | 2,270 | $336K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.8% | 1,363 | 1,310 | $208K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.1% | 2,839 | 2,675 | $169K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.1% | 4,327 | 3,610 | $117K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.9% | 999 | 910 | $106K |
| 71045 | Radiologic examination, chest; single view | 1.9% | 1,415 | 1,336 | $102K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 1,309 | 1,232 | $85K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.2% | 2,685 | 2,568 | $64K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 125 | 121 | $47K |
48 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,723 | $45K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 435 | $36K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 41 | $27K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 214 | $24K |
| 80053 | Comprehensive metabolic panel | <1% | 3,435 | $22K |
| J3490 | Unclassified drugs | <1% | 861 | $20K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 129 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,290 | $15K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 132 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 221 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 367 | $8K |
| 84484 | <1% | 1,209 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 277 | $7K |
| 81001 | <1% | 1,909 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 83 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 450 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 172 | $4K |
| 83735 | <1% | 957 | $4K | |
| 83690 | <1% | 535 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,799 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 43 | $2K |
| 81025 | <1% | 240 | $2K | |
| 81003 | <1% | 732 | $2K | |
| 99199 | Unlisted special service, procedure or report | <1% | 271 | $2K |
| 85027 | <1% | 323 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 324 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 99 | $1K |
| 83605 | <1% | 157 | $1K | |
| 87088 | <1% | 94 | $782.08 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 142 | $670.62 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 86 | $649.46 |
| 82248 | <1% | 120 | $568.08 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 74 | $566.95 |
| 80061 | Lipid panel | <1% | 26 | $277.86 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 43 | $271.35 |
| 87070 | <1% | 29 | $257.52 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $256.55 |
| 11720 | <1% | 12 | $200.05 | |
| 87430 | <1% | 14 | $199.92 | |
| G0127 | Trimming of dystrophic nails, any number | <1% | 25 | $192.92 |
| 82077 | <1% | 61 | $176.40 | |
| 87040 | <1% | 25 | $172.39 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $118.53 |
| 87807 | <1% | 13 | $99.96 | |
| 82962 | <1% | 62 | $97.80 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 13 | $75.74 |
| S0028 | Injection, famotidine, 20 mg | <1% | 12 | $66.51 |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | <1% | 107 | $14.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWARLITNER, TODD (CFO)
| Provider | Location | Paid |
|---|---|---|
| East Carolina Health - Chowan INC | Edenton, NC | $9.54M |
| The Outer Banks Hospital INC | Nags Head, NC | $1.07M |
| Outer Banks Professional Services, LLC | Nags Head, NC | $807K |
| The Outer Banks Hospital INC | Nags Head, NC | $6K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.